GridAI Technologies GRDX
NASDAQ GRDX
$2.97 -0.05 (-1.66%)
At close: Sep 10, 2026 · 4:00 PM EDT

GridAI Technologies (GRDX) Preferred Stock Liabilities (2024 - 2026)

GridAI Technologies' (GRDX) quarterly Preferred Stock Liabilities came in at $3.9 million in Q2 2026, down 93.68% on a YoY basis from $61.7 million in Q2 2025, and little changed quarter-over-quarter from $3.9 million in Q4 2025.

Analysis

GridAI Technologies (GRDX) Preferred Stock Liabilities (2024 - 2026) Analysis & Trends

GridAI Technologies (GRDX) has reported Preferred Stock Liabilities for 3 consecutive years, with $3.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Preferred Stock Liabilities fell 93.68% year-over-year to $3.9 million; the trailing twelve-month figure through Jun 2026 stood at $3.9 million (down 93.68% YoY), and the FY2025 full-year result was $3.9 million, down 93.68% from the prior year.
  • Preferred Stock Liabilities held at $3.9 million in Q2 2026 per GRDX's latest filing, from $3.9 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $61.7 million in Q1 2024 and bottomed at $3.9 million in Q4 2025.
  • Historically, Preferred Stock Liabilities has averaged $48.8 million across 3 years, with a median of $61.7 million in 2024.
  • The widest YoY moves for Preferred Stock Liabilities: up 0.0% in 2025, down 93.68% in 2025.
  • Over 3 years, Preferred Stock Liabilities stood at $61.7 million in 2024, then tumbled by 93.68% to $3.9 million in 2025, then changed by 0.0% to $3.9 million in 2026.
  • According to Business Quant data, Preferred Stock Liabilities over the past three periods registered $3.9 million, $3.9 million, and $61.7 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 GridAI Technologies 19.07 Mn 19.07 Mn -36,514.00 3.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.90 Mn
Dec 31, 2025 3.90 Mn
Sep 30, 2025 61.68 Mn
Jun 30, 2025 61.68 Mn
Mar 31, 2025 61.68 Mn
Dec 31, 2024 61.68 Mn
Sep 30, 2024 61.68 Mn
Jun 30, 2024 61.68 Mn
Mar 31, 2024 61.68 Mn